Related Experiment Video
Updated: Feb 25, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy
James J Starc1, Ryan A Moore2, Mantosh S Rattan3
1Division of Pediatric Cardiology, Mount Sinai Medical Center, One Gustave L. Levy Place, Post Box 1201, New York, NY, 10029, USA. james.starc@mssm.edu.
Insights
Duchenne muscular dystrophy (DMD) patients show higher myocardial fibrosis (ECV) than controls, detected via cardiovascular magnetic resonance (CMR). This ECV marker correlates with impaired heart function, aiding early cardiac involvement detection in DMD.
Area of Science:
- Cardiology
- Genetics
- Biomedical Imaging
Background:
- Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder associated with life-threatening cardiomyopathy.
- Myocardial fibrosis is a key feature of DMD cardiomyopathy, leading to heart failure and arrhythmias.
- Early detection of cardiac involvement in DMD is crucial for improved patient outcomes.
Purpose of the Study:
- To quantify myocardial extracellular volume (ECV) in pediatric patients with DMD using cardiovascular magnetic resonance (CMR) T1 mapping.
- To correlate ECV measurements with left ventricular (LV) function metrics in DMD patients.
- To assess the utility of ECV as a non-invasive marker for cardiac involvement in DMD.
Main Methods:
- Retrospective analysis of CMR data from 47 pediatric DMD patients.
- Quantification of global myocardial ECV using T1 mapping.
- Correlation analysis between ECV and LV function parameters (ejection fraction, end-diastolic volume) and late gadolinium enhancement (LGE).
Main Results:
- Pediatric DMD patients exhibited significantly higher global myocardial ECV (29 ± 6%) compared to published normal values (24 ± 2%).
- Elevated ECV levels correlated with reduced left ventricular ejection fraction (r = -0.46) and increased indexed LV end-diastolic volume (r = 0.41).
- No significant difference in ECV was observed between DMD patients with and without LGE (p=0.0717).
Conclusions:
- CMR T1 mapping is a feasible method for ECV quantification in DMD patients.
- Global myocardial ECV is elevated in pediatric DMD and correlates with impaired LV function.
- ECV serves as a valuable non-invasive tool for assessing cardiac involvement and guiding management in DMD.
Abstract:
Duchenne muscular dystrophy (DMD) is a genetic, X-linked recessive disease with an associated cardiomyopathy characterized by myocardial fibrosis leading to heart failure, arrhythmias, and death. Earlier detection and treatment of cardiac involvement in DMD hold potential to improve outcomes. Cardiovascular magnetic resonance (CMR) extracellular volume (ECV) quantification using T1 mapping is a histologically validated, non-invasive marker of diffuse fibrosis. This study aims to determine the ECV in a pediatric DMD population, and correlate it with metrics of left ventricular function. A retrospective review of pediatric DMD subjects who underwent CMR at a single institution. A total of 47 DMD patients (mean age 14 ± 2 years) were included for analysis. Global myocardial ECV was significantly higher in the DMD group (29 ± 6%) compared with published normal values (24 ± 2%, p = 0.0001). Higher ECV values correlate with indices of left ventricular function, including decreased left ventricular ejection fraction (r = -0.46, p = 0.001) and indexed left ventricular end diastolic volume (r = 0.41, p = 0.004). ECV was not significantly higher in DMD patients with late gadolinium enhancement (LGE) (30 ± 7%) compared to DMD patients without LGE (27 ± 5%, p = 0.0717). CMR T1 mapping is a feasible method for quantification of ECV in patients with DMD. Global myocardial ECV is significantly higher in the DMD population compared to healthy controls and correlates with other metrics of myocardial function. Global myocardial ECV may serve as an important tool to determine cardiac involvement in DMD population and help guide medical management.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Satellite Stem Cells and Muscular Dystrophy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure II: Pathophysiology

